EuroscreenFast and GW Vitek Announce Strategic Distribution Partnership in Korea

EuroscreenFast and GW Vitek, a prominent distributor in the east-Asian biotechnology and drug development market, are pleased to announce a strategic collaboration whereby GW Vitek will represent EuroscreenFast’s innovative discovery and lead optimisation capabilities in the Republic of Korea.


While EuroscreenFast has some presence in East-Asia, this partnership will enable significant expansion of its commercial reach into the Korean market. Through the leveraging of GW Vitek’s extensive distribution network and market expertise, EuroscreenFast aims to provide its cutting-edge GPCR cell-based assay services and a robust deorphanisation offering to a broader range of clients.


“We are absolutely delighted to partner with GW Vitek,” said Dr Laurent Meeus, EuroscreenFast’s Chief Scientist & General Manager. “This collaboration aligns perfectly with our strategic goal to expand our presence in key international markets and bring our innovative solutions to the world.”


“This partnership with EuroscreenFast further strengthens GW Vitek’s position as Korea’s go-to provider of biotherapeutic research solutions for both biologics and chemical therapeutics,” said Jaewon Yang, CEO at GW Vitek. “We are excited to offer EuroscreenFast’s advanced GPCR screening technologies to our clients, which is a new area of expansion for our already broad catalogue of instruments and wet-lab services.”


Korean companies developing human therapeutics are encouraged to contact GW Vitek to advance their GPCR drug discovery programs using EuroscreenFast’s state-of-the-art technologies.


For more information, please contact: